Journal of Clinical Hypertension · 2007 · 114 citations · 11 references
Public HealthMaternal HealthObstetricsHigh-risk PregnancyMaternal MortalityMaternal-fetal MedicineEclampsiaHypertension PreventionHypertensive DisordersPregnancyPregnancy PhysiologyPregnancy-induced HypertensionCardiovascular Disease MortalityHypertensive Disorder ComorbidityHypertensive Disorder PreventionHypertensive Disorders ScreeningPreeclampsia PathophysiologyPregnancy-related HypertensionScreening In High-risk PregnanciesTreatment Strategies
Hypertensive pregnancy disorders complicate 10% of all pregnancies and cover a spectrum of conditions, namely preeclampsia, eclampsia, and chronic and gestational hypertension. Preeclampsia is a pregnancy-specific disorder clinically characterized by hypertension and proteinuria that occurs after 20 weeks of gestation. It remains a leading cause of both fetal and maternal morbidity and mortality worldwide. Traditionally, hypertensive pregnancy disorders were considered not to have any long-term impact on mothers' cardiovascular health; however, recent studies consistently have supported the role of hypertension in pregnancy as a risk factor for cardiovascular disease later in life. Therefore, improved screening, and preventive and treatment strategies may not only optimize management of hypertensive pregnancy disorders, but may have a long-term impact on women's cardiovascular events and outcomes years after the affected pregnancies. This article will provide a brief review of hypertensive pregnancy disorders and important recent discoveries regarding their pathogeneses, while focusing on current diagnostic and treatment strategies.
11
Sharon E. Maynard, Jiang-Yong Min, Jaime R. Merchan et al. · Journal of Clinical Investigation · 2003 · 4K citations · Full text
Low-Dose Aspirin to Prevent Preeclampsia in Women at High Risk
Steve N. Caritis, Baha M. Sibai, John C. Hauth et al. · New England Journal of Medicine · 1998 · 670 citations · Full text